However, a study using a mouse model of subcutaneous osteosarcoma xenografts, aiming to determine the linkage between tumor growth velocity and DKK1 level, reported a statistically significant decrease in tumor growth velocity in mice treated with BHQ880 compared with control mice. This evidence concerns the gene DKK1 and osteosarcoma.